"John Bordynuik is not a director or officer for more than

New Post Public Reply Private Reply Replies (1) Message Board
3.14159265359
Quote:
"John Bordynuik is not a director or officer for more than three years. He is no longer an employee of PTOI.

You apparently think the facility not operational for nearly two years is some sort of issue but everyone knows the situation and I am trying to understand why that fact is a worthy issue to discuss."


It's worth going through this point by point, to see where folks are still being fooled by this trainwreck of a company:


>> He is only a shareholder.

Says who? Proof? Given the lifestyle he is currently living, he may have sold every single share he ever had at much higher prices, long, long ago.


>>John Bordynuik is not a director or officer for more than three years.

It's true. John Bordynuik was banned from being an officer and director for securities fraud. Not just by one regulatory agency, but by two independent regulatory agencies in two different countries. In his OSC settlement, Bordynuik admitted to series of fraudulent acts he committed between 2009 and 2011.

This history is still broadly important, even if the current shareholders don't care. Heddle is trying to sell a device that was designed by a self-admitted crook and liar, without any education or experience in the pyrolysis field.

Anyone hearing this for the first time would immediately conclude that these idle hunks of metal were never anything more than props in a stock scam.


"You apparently think the facility not operational for nearly two years is some sort of issue but everyone knows the situation and I am trying to understand why that fact is a worthy issue to discuss."

Let's analyze this. We have a machine designed by a liar and a crook, who was twice banned for securities fraud. He left the company long ago.

PTOI has cratered by almost 90% in two years.

Does anyone really think the 90% haircut would have happened if Heddle had been selling processors or producing cheap oil for a profit all of that time?!?!?!

Of course the market cares.

Plastic2Oil, Inc. (PTOI) Stock Research Links

PTOI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Halozyme's Upcoming Investment Presentation at Healthcare Conference

Updated Category News Views 280

Halozyme's Participation in Major Healthcare Conference Halozyme Therapeutics, Inc. (NASDAQ: HALO) is set to showcase its advancements at an important healthcare conference. Dr. Helen Torley, the president and CEO, will present and engage in investor meetings, highlighting the company's innovative approaches in the biopharmaceutical sector. Details of the Presentation The...

Continue Reading
Emerging Markets Surge Ahead with Historic Bond Sales Strategy

Updated Category News Views 241

Emerging Markets Adjust with Record Bond Sales Amid economic uncertainty, borrowers in developing regions are intensifying their efforts to navigate potential market turbulence, particularly due to significant fluctuations influenced by US economic conditions. Authorities and businesses have proactively begun securing funds through bond sales, reflecting a strategic move...

Continue Reading
Multi Ways Holdings Reflects on Fiscal Year 2024 Performance

Updated Category News Views 167

Multi Ways Holdings Limited Reports on Financial Results Multi Ways Holdings Limited (NYSE American: MWG), a prominent provider of heavy construction equipment, has recently shared its financial outcomes for the fiscal year 2024. With a focus on innovation and customer satisfaction in Singapore and neighboring regions, the company continues to adapt to the dynamic market...

Continue Reading
Neurocrine Adjusts Course Following Luvadaxistat Study Setback

Updated Category News Views 117

Neurocrine Biosciences Shifts Strategy After Luvadaxistat Trial Neurocrine Biosciences Inc. (NASDAQ: NBIX) has made revisions to its strategic approach following the outcomes of the ERUDITE phase two clinical trial involving luvadaxistat (NBI-1065844). This investigational treatment aimed at addressing cognitive impairment in schizophrenia did not achieve its primary...

Continue Reading
Rinnai America Leads Coalition Against DOE Water Heater Rule

Updated Category News Views 294

Rinnai America Takes Action Against DOE Regulations Rinnai America Corporation, a prominent manufacturer of noncondensing tankless water heaters, has joined forces with 21 state attorneys general and various business groups to challenge the recent final rule issued by the U.S. Department of Energy (DOE) concerning consumer tankless water heaters. This action follows a...

Continue Reading